Definitive Healthcare Forecast, price target & analysts
Definitive Healthcare Target price 2026 - Analyst rating & recommendation
Definitive Healthcare Classifications & Recommendation
Definitive Healthcare Price Target
| Target Price | $1.28 |
| Price | $0.96 |
| Potential |
33.06%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Definitive Healthcare 2027 .
The average Definitive Healthcare target price is $1.28.
This is
33.06%
register free of charge
$3.15
228.74%
register free of charge
$0.71
26.22%
register free of charge
|
|
| A rating was issued by 16 analysts: 1 Analysts recommend Definitive Healthcare to buy, 7 to hold and 8 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Definitive Healthcare stock has an average upside potential 2027 of
33.06%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 241.52 | 228.08 |
| 4.23% | 5.56% | |
| EBITDA Margin | 7.95% | 26.21% |
| 28.05% | 229.53% | |
| Net Margin | -57.52% | 12.54% |
| 64.88% | 121.80% |
11 Analysts have issued a sales forecast Definitive Healthcare 2026 . The average Definitive Healthcare sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an Definitive Healthcare EBITDA forecast 2026. The average Definitive Healthcare EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Definitive Healthcare Analysts have issued a net profit forecast 2026. The average Definitive Healthcare net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.30 | 0.20 |
| 63.28% | 115.38% | |
| P/E | 4.88 | |
| EV/Sales | 0.51 |
11 Analysts have issued a Definitive Healthcare forecast for earnings per share. The average Definitive Healthcare EPS is
This results in the following potential growth metrics and future valuations:
Definitive Healthcare...
Current Definitive Healthcare Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Jun 29 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Mar 30 2026 |
| Stephens & Co. |
Locked
➜
Locked
|
Locked | Feb 27 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Feb 27 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Dec 09 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Nov 10 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Jun 29 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Mar 30 2026 |
|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Feb 27 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Feb 27 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Dec 09 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Nov 10 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
